1933 Industries Inc (CSE:TGIF) (OTCQX:TGIFF), the Vancouver cannabis cultivation and production company, has hired CB1 Capital Advisors LLC, a New York advisory firm, to serve as a strategic business adviser for a year.
As an advisory firm focused on cannabinoid-based wellness strategies, CB1 Capital will provide business development advice to 1933 that includes analyzing investments and partnerships.
“We have accumulated an equity position in 1933 Industries and we look forward to working in an advisory capacity to assist the company in evaluating and pursuing business opportunities in the US,” said Todd Harrison, chief investment officer of CB1 Capital Management.
Operating via three subsidiaries, 1933 specializes in licensed medical and recreational cannabis cultivation and production as well as hemp-based and CBD-infused products and CBD extraction services.
The company owns 91% of both the Alternative Medicine Association and Infused MFG and 100% of Spire Global Strategy, a cannabis advisory firm.
READ: 1933 Industries stokes Las Vegas capacity expansion in anticipation of medical and recreational cannabis product demand
1933 shares added 10.2% to trade at $0.41 in New York in the morning trading session on Tuesday.
Contact Ellen Kelleher at email@example.com